跳至主要内容
临床试验/NCT06747299
NCT06747299尚未招募不适用

The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study

Ruijin Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
试验地点
1
主要终点
Evaluation the value of Artificial Intelligence-based 18F-FDG PET/CT of T-NK Cell Lymphoma

研究概览

简要总结

Based on the PET/CT imaging data of patients with T-NK cell lymphoma, machine learning and deep learning methods are used to extract imaging features, establish a T-NK cell lymphoma prediction model, and provide more scientific and accurate prognosis prediction for the clinic.

详细描述

This study adopts a multicenter retrospective cohort study design,we provided PET/CT of 200 patients with T-NK cell lymphoma as an external validation set for model validation.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pathological histology confirmed as T-NK Cell Lymphoma; 2.18F-FDG PET/CT examination before treatment;
  • Using modern best practice treatment options;
  • Complete clinicopathological and follow-up data were obtained.

排除标准

  • The patient had previously received antitumor therapy;
  • The patient had a history of other tumors;
  • Incomplete clinical information or imaging data;
  • Concomitant other malignant tumors.

结局指标

主要结局

Evaluation the value of Artificial Intelligence-based 18F-FDG PET/CT of T-NK Cell Lymphoma

时间窗: Within 1 week of enrollment and after 3 months treatment

The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma

次要结局

  • Progress free survival(3 years)
  • Overall survival(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

GUO RUI

Deputy director

Ruijin Hospital

研究点 (1)

Loading locations...

相似试验